tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals Plc (BDRX)
:BDRX

Biodexa Pharmaceuticals (BDRX) Price & Analysis

Compare
492 Followers

BDRX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.87%<0.01%<0.01%98.13%
1.87%
Insiders
<0.01%
Mutual Funds
<0.01% Other Institutional Investors
98.13% Public Companies and Individual Investors

BDRX FAQ

What was Biodexa Pharmaceuticals Plc’s price range in the past 12 months?
Biodexa Pharmaceuticals Plc lowest stock price was $1.01 and its highest was $41.50 in the past 12 months.
    What is Biodexa Pharmaceuticals Plc’s market cap?
    Biodexa Pharmaceuticals Plc’s market cap is $735.45K.
      When is Biodexa Pharmaceuticals Plc’s upcoming earnings report date?
      Biodexa Pharmaceuticals Plc’s upcoming earnings report date is Sep 11, 2025 which is in 88 days.
        How were Biodexa Pharmaceuticals Plc’s earnings last quarter?
        Biodexa Pharmaceuticals Plc released its earnings results on Apr 11, 2025. The company reported -$0.001 earnings per share for the quarter, the consensus estimate of -$0.001 by $0.
          Is Biodexa Pharmaceuticals Plc overvalued?
          According to Wall Street analysts Biodexa Pharmaceuticals Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Biodexa Pharmaceuticals Plc pay dividends?
            Biodexa Pharmaceuticals Plc does not currently pay dividends.
            What is Biodexa Pharmaceuticals Plc’s EPS estimate?
            Biodexa Pharmaceuticals Plc’s EPS estimate is 0.
              How many shares outstanding does Biodexa Pharmaceuticals Plc have?
              Biodexa Pharmaceuticals Plc has 5,050,631 shares outstanding.
                What happened to Biodexa Pharmaceuticals Plc’s price movement after its last earnings report?
                Biodexa Pharmaceuticals Plc reported an EPS of -$0.001 in its last earnings report, expectations of -$0.001. Following the earnings report the stock price went up 12.739%.
                  Which hedge fund is a major shareholder of Biodexa Pharmaceuticals Plc?
                  Currently, no hedge funds are holding shares in BDRX

                  Company Description

                  Biodexa Pharmaceuticals Plc

                  Biodexa Pharmaceuticals (BDRX) is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. Operating primarily in the pharmaceutical sector, the company specializes in the research and development of drug delivery systems and proprietary drug formulations designed to enhance patient outcomes. Its core products include advanced pharmaceutical compounds and delivery technologies that address unmet medical needs in various therapeutic areas.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Xoma
                  Marinus
                  Akari Therapeutics
                  Fennec Pharmaceuticals
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis